Roche Holding AG Ordinary Shares new

ROP: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|NSLOCK|?^kLOCK|$Z#yCxx!

Roche Earnings: Continuing Steady Underlying Growth in 2026 as Late-Stage Pipeline Shines

Roche saw 7% sales growth at constant exchange rates in 2025 (2% as reported), with core earnings per share growth of 11% (4% as reported). Management guided to mid-single-digit sales growth and high-single-digit core EPS growth in 2026 at constant currencies. The ADRs rose 5% intraday on Jan. 29.

Sponsor Center